ACADIA Pharmaceuticals Inc. (LON:0A4W)

ACADIA Pharmaceuticals Statistics

Total Valuation

LON:0A4W has a market cap or net worth of GBP 2.96 billion. The enterprise value is 2.44 billion.

Market Cap	2.96B
Enterprise Value	2.44B

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	166.39M
Shares Outstanding	n/a
Shares Change (YoY)	+1.10%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	115.87M

Valuation Ratios

The trailing PE ratio is 18.27 and the forward PE ratio is 33.12.

PE Ratio	18.27
Forward PE	33.12
PS Ratio	3.98
PB Ratio	4.93
P/TBV Ratio	5.73
P/FCF Ratio	21.69
P/OCF Ratio	21.60
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.83, with an EV/FCF ratio of 17.90.

EV / Earnings	15.08
EV / Sales	3.27
EV / EBITDA	28.83
EV / EBIT	36.95
EV / FCF	17.90

Financial Position

The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.07.

Current Ratio	2.91
Quick Ratio	2.67
Debt / Equity	0.07
Debt / EBITDA	0.49
Debt / FCF	0.30
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 33.18% and return on invested capital (ROIC) is 7.77%.

Return on Equity (ROE)	33.18%
Return on Assets (ROA)	5.28%
Return on Invested Capital (ROIC)	7.77%
Return on Capital Employed (ROCE)	10.08%
Revenue Per Employee	1.14M
Profits Per Employee	247,943
Employee Count	654
Asset Turnover	0.95
Inventory Turnover	8.30

Taxes

In the past 12 months, LON:0A4W has paid 33.37 million in taxes.

Income Tax	33.37M
Effective Tax Rate	17.07%

Stock Price Statistics

The stock price has decreased by -31.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.17%
50-Day Moving Average	17.41
200-Day Moving Average	16.42
Relative Strength Index (RSI)	58.25
Average Volume (20 Days)	2,167

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.71

Income Statement

In the last 12 months, LON:0A4W had revenue of GBP 743.68 million and earned 162.15 million in profits. Earnings per share was 0.97.

Revenue	743.68M
Gross Profit	447.83M
Operating Income	65.91M
Pretax Income	195.53M
Net Income	162.15M
EBITDA	75.88M
EBIT	65.91M
Earnings Per Share (EPS)	0.97

Balance Sheet

The company has 556.18 million in cash and 41.09 million in debt, giving a net cash position of 515.09 million.

Cash & Cash Equivalents	556.18M
Total Debt	41.09M
Net Cash	515.09M
Net Cash Per Share	n/a
Equity (Book Value)	600.26M
Book Value Per Share	3.56
Working Capital	460.22M

Cash Flow

In the last 12 months, operating cash flow was 137.15 million and capital expenditures -598,518, giving a free cash flow of 136.55 million.

Operating Cash Flow	137.15M
Capital Expenditures	-598,518
Free Cash Flow	136.55M
FCF Per Share	n/a

Margins

Gross margin is 60.22%, with operating and profit margins of 8.86% and 21.80%.

Gross Margin	60.22%
Operating Margin	8.86%
Pretax Margin	26.29%
Profit Margin	21.80%
EBITDA Margin	10.20%
EBIT Margin	8.86%
FCF Margin	18.36%

Dividends & Yields

LON:0A4W does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.10%
Shareholder Yield	-1.10%
Earnings Yield	5.47%
FCF Yield	4.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0A4W has an Altman Z-Score of 3.53 and a Piotroski F-Score of 5.

Altman Z-Score	3.53
Piotroski F-Score	5